Our recent BIND Paper has garnered some attention, including over 1 million views for one article on Twitter.

Our 3rd and final paper of the benzodiazepine survey is the focus of a recent Psychology Today article.

The third and final paper from the benzodiazepine survey — which formerly introduces BIND terminology — is now published.

Join the benzodiazepine research team for a lively discussion about BIND.

Fluoroquinolones can cause neuropathy and other side effects, especially in benzodiazepine-affected individuals.

Video of my conversation on Angela Peacock's channel is now available. Please check it out.

As part of her lived-experience series, D E Foster will join Angela Peacock on her podcast tomorrow, June 9th.

Naftal Benisty is the creator and host of the podcast, “Benzo Tired.” A social worker by trade, Naftal’s personal experience with kindling, seizures, and multiple prescriptions for benzodiazepines steered him into the world of benzo advocacy. In our conversation, Naftal shares his benzo story and the reasons he decided to start a podcast. We also talk about seizures, the indefinite hold, BIND, deprescribing guidelines, medical education, remaining positive, and so much more.

A recent article in Forbes Health discusses medication classes commonly prescribed for anxiety. As with so many articles on benzodiazepines and antidepressants, this one includes some valuable information — but it also falls far short when it comes to dependence and withdrawal. In the May 18th Forbes Health article, "Anxiety Medication: Types and Side Effects," contributing author Becca Stanek explores four classes of psychiatric medication. These are selective serotonin reu